ZNF362
gene geneOn this page
Also known as FLJ25476lin-29RN
Summary
ZNF362 (zinc finger protein 362, HGNC:18079) is a protein-coding gene on chromosome 1p35.1, encoding Zinc finger protein 362 (Q5T0B9). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be located in nucleus.
Source: NCBI Gene 149076 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 54 total
- Transcription factor: yes — 25 downstream targets (CollecTRI)
- MANE Select transcript:
NM_152493
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:18079 |
| Approved symbol | ZNF362 |
| Name | zinc finger protein 362 |
| Location | 1p35.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ25476, lin-29, RN |
| Ensembl gene | ENSG00000160094 |
| Ensembl biotype | protein_coding |
| Entrez | 149076 |
Gene structure
Transcript identifiers
Ensembl transcripts: 6 — 4 protein_coding, 1 retained_intron, 1 protein_coding_CDS_not_defined
ENST00000373428, ENST00000477934, ENST00000483388, ENST00000490959, ENST00000539719, ENST00000926820
RefSeq mRNA: 2 — MANE Select: NM_152493
NM_001370212, NM_152493
CCDS: CCDS377
Canonical transcript exons
ENST00000539719 — 9 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000916665 | 33294937 | 33295015 |
| ENSE00000956969 | 33295147 | 33295305 |
| ENSE00001049709 | 33276348 | 33276594 |
| ENSE00001066034 | 33280124 | 33280457 |
| ENSE00001066037 | 33281587 | 33281811 |
| ENSE00001733539 | 33298930 | 33300719 |
| ENSE00002257162 | 33256492 | 33256654 |
| ENSE00003572143 | 33270487 | 33270612 |
| ENSE00003603550 | 33276100 | 33276163 |
Expression profiles
Bgee: expression breadth ubiquitous, 265 present calls, max score 95.10.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 17.8134 / max 117.1677, expressed in 1759 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 2056 | 17.6466 | 1759 |
| 2057 | 0.1668 | 60 |
Top tissues by expression
287 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| parotid gland | UBERON:0001831 | 95.10 | gold quality |
| pigmented layer of retina | UBERON:0001782 | 94.92 | gold quality |
| nipple | UBERON:0002030 | 93.98 | gold quality |
| cortical plate | UBERON:0005343 | 93.97 | gold quality |
| caput epididymis | UBERON:0004358 | 93.90 | gold quality |
| cauda epididymis | UBERON:0004360 | 93.66 | gold quality |
| corpus epididymis | UBERON:0004359 | 92.86 | gold quality |
| ascending aorta | UBERON:0001496 | 92.55 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 92.55 | gold quality |
| thoracic aorta | UBERON:0001515 | 92.54 | gold quality |
| right coronary artery | UBERON:0001625 | 92.45 | gold quality |
| saphenous vein | UBERON:0007318 | 92.28 | gold quality |
| aorta | UBERON:0000947 | 92.25 | gold quality |
| urethra | UBERON:0000057 | 92.16 | gold quality |
| ganglionic eminence | UBERON:0004023 | 92.12 | gold quality |
| popliteal artery | UBERON:0002250 | 92.03 | gold quality |
| tibial artery | UBERON:0007610 | 92.02 | gold quality |
| renal medulla | UBERON:0000362 | 91.96 | gold quality |
| primary visual cortex | UBERON:0002436 | 91.88 | gold quality |
| tibia | UBERON:0000979 | 91.83 | gold quality |
| cerebellar vermis | UBERON:0004720 | 91.77 | gold quality |
| mammalian vulva | UBERON:0000997 | 91.75 | gold quality |
| skin of hip | UBERON:0001554 | 91.59 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 91.21 | gold quality |
| Brodmann (1909) area 23 | UBERON:0013554 | 91.15 | gold quality |
| medial globus pallidus | UBERON:0002477 | 90.95 | gold quality |
| vena cava | UBERON:0004087 | 90.87 | gold quality |
| trabecular bone tissue | UBERON:0002483 | 90.86 | gold quality |
| entorhinal cortex | UBERON:0002728 | 90.83 | gold quality |
| apex of heart | UBERON:0002098 | 90.79 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 9.81 |
Regulation
Is transcription factor: yes
Downstream targets (CollecTRI)
25 targets.
| Target | Regulation |
|---|---|
| AATF | |
| ACAT1 | |
| CAT | |
| CIITA | |
| CNTN2 | |
| CRH | |
| FGFR1 | |
| GSTP1 | |
| HBB | |
| HRAS | |
| HTR1A | |
| IFNB1 | |
| IGF1 | |
| KDR | |
| MBP | |
| MDM2 | |
| MMP10 | |
| NODAL | |
| PSG5 | |
| REG1A | |
| RNASE2 | |
| SLC4A1 | |
| SUPT7L | |
| TIMP1 | |
| U2AF1 |
JASPAR motifs
| Motif | Name | Family |
|---|---|---|
| MA2593.1 | ZNF362 | More than 3 adjacent zinc fingers |
JASPAR matrix evidence (PMIDs): PMID:39605320
miRNA regulators (miRDB)
146 targeting ZNF362, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-9-5P | 100.00 | 72.28 | 2361 |
| HSA-MIR-4500 | 99.99 | 72.72 | 2367 |
| HSA-MIR-12136 | 99.98 | 72.81 | 5713 |
| HSA-MIR-568 | 99.98 | 69.86 | 2084 |
| HSA-MIR-4715-3P | 99.98 | 66.03 | 670 |
| HSA-MIR-520D-5P | 99.98 | 73.34 | 4883 |
| HSA-MIR-524-5P | 99.98 | 73.43 | 4882 |
| HSA-MIR-6888-3P | 99.97 | 65.95 | 1170 |
| HSA-MIR-495-3P | 99.96 | 72.81 | 4197 |
| HSA-MIR-5688 | 99.96 | 73.23 | 4504 |
| HSA-MIR-302E | 99.96 | 70.74 | 2669 |
| HSA-MIR-551B-5P | 99.96 | 71.28 | 3493 |
| HSA-MIR-6778-3P | 99.96 | 67.29 | 2693 |
| HSA-MIR-144-3P | 99.94 | 73.98 | 2698 |
| HSA-MIR-539-5P | 99.93 | 70.30 | 2855 |
| HSA-MIR-3119 | 99.92 | 71.34 | 2390 |
| HSA-MIR-338-5P | 99.92 | 72.34 | 2951 |
| HSA-MIR-497-5P | 99.92 | 71.83 | 2674 |
| HSA-MIR-106A-5P | 99.90 | 73.94 | 2683 |
| HSA-MIR-627-3P | 99.90 | 71.42 | 3316 |
| HSA-MIR-15A-5P | 99.90 | 72.80 | 2787 |
| HSA-MIR-15B-5P | 99.90 | 72.78 | 2798 |
| HSA-MIR-16-5P | 99.90 | 72.80 | 2780 |
| HSA-MIR-195-5P | 99.90 | 72.81 | 2805 |
| HSA-MIR-302A-3P | 99.89 | 71.23 | 1777 |
| HSA-MIR-302B-3P | 99.89 | 71.23 | 1777 |
| HSA-MIR-302C-3P | 99.89 | 71.20 | 1778 |
| HSA-MIR-302D-3P | 99.89 | 71.25 | 1777 |
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | znf362a | ENSDARG00000060900 |
| danio_rerio | znf362b | ENSDARG00000062231 |
| mus_musculus | Zfp362 | ENSMUSG00000028799 |
| rattus_norvegicus | Zfp362 | ENSRNOG00000043364 |
Paralogs (36): ZBTB32 (ENSG00000011590), SNAI2 (ENSG00000019549), PRDM1 (ENSG00000057657), PRDM6 (ENSG00000061455), ZNF76 (ENSG00000065029), PATZ1 (ENSG00000100105), MAZ (ENSG00000103495), ZBTB16 (ENSG00000109906), ZNF451 (ENSG00000112200), ZBTB45 (ENSG00000119574), ZNF410 (ENSG00000119725), SNAI1 (ENSG00000124216), ZNF384 (ENSG00000126746), ZBTB1 (ENSG00000126804), VEZF1 (ENSG00000136451), PRDM14 (ENSG00000147596), ZNF276 (ENSG00000158805), ZNF653 (ENSG00000161914), ZNF281 (ENSG00000162702), ZNF148 (ENSG00000163848), ZNF143 (ENSG00000166478), HIC2 (ENSG00000169635), PRDM10 (ENSG00000170325), ZNF296 (ENSG00000170684), ZNF692 (ENSG00000171163), ZNF575 (ENSG00000176472), HIC1 (ENSG00000177374), ZBTB18 (ENSG00000179456), ZBTB42 (ENSG00000179627), ZBTB20 (ENSG00000181722), ZBTB7C (ENSG00000184828), SNAI3 (ENSG00000185669), ZFP91 (ENSG00000186660), MTF1 (ENSG00000188786), SCRT2 (ENSG00000215397), SCRT1 (ENSG00000261678)
Protein
Protein identifiers
Zinc finger protein 362 — Q5T0B9 (reviewed: Q5T0B9)
All UniProt accessions (2): Q5T0B9, F5H055
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
RefSeq proteins (2): NP_001357141, NP_689706* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096
UniProt features (16 total): zinc finger region 6, region of interest 4, modified residue 2, chain 1, compositionally biased region 1, cross-link 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5T0B9-F1 | 57.63 | 0.00 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (3): 162, 404, 198
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 241 (showing top):
TGGTGCT_MIR29A_MIR29B_MIR29C, E2F_Q4, E2F_Q4_01, FREAC2_01, E2F4DP1_01, TGCTGCT_MIR15A_MIR16_MIR15B_MIR195_MIR424_MIR497, AAGCCAT_MIR135A_MIR135B, MAZ_Q6, GTCTACC_MIR379, MEF2_02, GGCNKCCATNK_UNKNOWN, SENESE_HDAC1_AND_HDAC2_TARGETS_DN, IRF7_01, E2F1DP1_01, E2F_Q3
GO Biological Process (1): regulation of transcription by RNA polymerase II (GO:0006357)
GO Molecular Function (5): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity (GO:0003700), zinc ion binding (GO:0008270), DNA binding (GO:0003677), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of DNA-templated transcription | 2 |
| transcription by RNA polymerase II | 1 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| transcription cis-regulatory region binding | 1 |
| transcription regulator activity | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
742 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF362 | TRIM71 | Q2Q1W2 | 724 |
| ZNF362 | ZNF512 | Q96ME7 | 651 |
| ZNF362 | ZNF451 | Q9Y4E5 | 572 |
| ZNF362 | SDAD1 | Q9NVU7 | 552 |
| ZNF362 | LIN28A | Q9H9Z2 | 544 |
| ZNF362 | AJM1 | C9J069 | 523 |
| ZNF362 | SRBD1 | Q8N5C6 | 490 |
| ZNF362 | LCN9 | Q8WX39 | 480 |
| ZNF362 | TTLL11 | Q8NHH1 | 476 |
| ZNF362 | Q5T8A5 | Q5T8A5 | 461 |
| ZNF362 | SACK1E | Q2M2I3 | 456 |
| ZNF362 | UNC119 | Q13432 | 450 |
| ZNF362 | NIPBL | Q6KC79 | 436 |
| ZNF362 | RRP15 | Q9Y3B9 | 435 |
| ZNF362 | RAD21 | O60216 | 427 |
IntAct
11 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZNF362 | ANKRA2 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| ARHGEF19 | NUP42 | psi-mi:“MI:0914”(association) | 0.350 |
| NOTCH2 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| H2BC10 | SMCHD1 | psi-mi:“MI:2364”(proximity) | 0.270 |
| AR | MED6 | psi-mi:“MI:2364”(proximity) | 0.270 |
| CDC14B | PES1 | psi-mi:“MI:2364”(proximity) | 0.270 |
| TLK2 | PES1 | psi-mi:“MI:2364”(proximity) | 0.270 |
| ZMYM2 | ZBTB5 | psi-mi:“MI:2364”(proximity) | 0.270 |
| ZMYM3 | TAF4 | psi-mi:“MI:2364”(proximity) | 0.270 |
| SUMO1 | CHD2 | psi-mi:“MI:0914”(association) | 0.000 |
BioGRID (43): ZNF362 (Proximity Label-MS), ZNF362 (Proximity Label-MS), ZNF362 (Affinity Capture-RNA), ZNF362 (Affinity Capture-MS), ZNF362 (Proximity Label-MS), ZNF362 (Proximity Label-MS), ZNF362 (Proximity Label-MS), ZNF362 (Proximity Label-MS), ZNF362 (Affinity Capture-MS), ZNF362 (Proximity Label-MS), ZNF362 (Affinity Capture-MS), ZNF362 (Affinity Capture-MS), ZNF362 (Affinity Capture-MS), ZNF362 (Affinity Capture-MS), ZNF362 (Proximity Label-MS)
ESM2 similar proteins: A0JPB4, A1L1J6, A2VDW9, A4IFJ6, O00409, O08876, O08900, O13089, O15060, O15062, O42410, O57415, O60315, O75626, O89091, P14404, P25932, P36197, P37275, P55878, P55879, P81183, Q03267, Q0VDT2, Q13422, Q33BP8, Q3BJS3, Q3UH06, Q499D0, Q5R9W9, Q5T0B9, Q5ZLR2, Q5ZM39, Q60636, Q62255, Q62947, Q64318, Q6DBW0, Q6NRM0, Q6XDT4
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
54 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 40 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1454 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:33256717:A:T | donor_gain | 1.0000 |
| 1:33276343:C:A | acceptor_gain | 1.0000 |
| 1:33276343:CGCA:C | acceptor_loss | 1.0000 |
| 1:33276344:GCA:G | acceptor_loss | 1.0000 |
| 1:33276345:CA:C | acceptor_loss | 1.0000 |
| 1:33276346:A:AG | acceptor_gain | 1.0000 |
| 1:33276346:A:AT | acceptor_loss | 1.0000 |
| 1:33276346:AGCT:A | acceptor_gain | 1.0000 |
| 1:33276346:AGCTG:A | acceptor_gain | 1.0000 |
| 1:33276347:G:GA | acceptor_gain | 1.0000 |
| 1:33276347:GC:G | acceptor_gain | 1.0000 |
| 1:33276347:GCT:G | acceptor_gain | 1.0000 |
| 1:33276347:GCTG:G | acceptor_gain | 1.0000 |
| 1:33276347:GCTGG:G | acceptor_gain | 1.0000 |
| 1:33276591:ACAG:A | donor_loss | 1.0000 |
| 1:33276593:AGGTA:A | donor_loss | 1.0000 |
| 1:33276595:GTAG:G | donor_loss | 1.0000 |
| 1:33276596:T:G | donor_loss | 1.0000 |
| 1:33281809:CAGG:C | donor_loss | 1.0000 |
| 1:33281810:AGG:A | donor_loss | 1.0000 |
| 1:33281812:G:GA | donor_loss | 1.0000 |
| 1:33281813:T:G | donor_loss | 1.0000 |
| 1:33295143:ACAGT:A | acceptor_loss | 1.0000 |
| 1:33295144:CA:C | acceptor_loss | 1.0000 |
| 1:33295145:A:AG | acceptor_gain | 1.0000 |
| 1:33295145:A:C | acceptor_loss | 1.0000 |
| 1:33295146:G:GA | acceptor_gain | 1.0000 |
| 1:33295146:GT:G | acceptor_gain | 1.0000 |
| 1:33295146:GTC:G | acceptor_gain | 1.0000 |
| 1:33295146:GTCT:G | acceptor_gain | 1.0000 |
AlphaMissense
2718 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:33281588:T:C | C229R | 1.000 |
| 1:33281597:T:C | C232R | 1.000 |
| 1:33281599:C:G | C232W | 1.000 |
| 1:33281672:T:C | C257R | 1.000 |
| 1:33281683:C:G | C260W | 1.000 |
| 1:33281693:T:C | F264L | 1.000 |
| 1:33281695:T:A | F264L | 1.000 |
| 1:33281695:T:G | F264L | 1.000 |
| 1:33281712:T:C | L270P | 1.000 |
| 1:33281720:C:G | H273D | 1.000 |
| 1:33281722:C:A | H273Q | 1.000 |
| 1:33281722:C:G | H273Q | 1.000 |
| 1:33281724:T:C | L274P | 1.000 |
| 1:33281756:T:C | C285R | 1.000 |
| 1:33281777:T:C | F292L | 1.000 |
| 1:33281779:C:A | F292L | 1.000 |
| 1:33281779:C:G | F292L | 1.000 |
| 1:33281796:T:C | L298P | 1.000 |
| 1:33294965:T:C | C313R | 1.000 |
| 1:33294992:T:C | F322L | 1.000 |
| 1:33294994:C:A | F322L | 1.000 |
| 1:33294994:C:G | F322L | 1.000 |
| 1:33295011:T:C | L328P | 1.000 |
| 1:33295150:C:G | H331D | 1.000 |
| 1:33295186:T:C | C343R | 1.000 |
| 1:33281588:T:A | C229S | 0.999 |
| 1:33281589:G:C | C229S | 0.999 |
| 1:33281590:T:G | C229W | 0.999 |
| 1:33281597:T:A | C232S | 0.999 |
| 1:33281598:G:A | C232Y | 0.999 |
dbSNP variants (sampled 300 via entrez): RS1000048917 (1:33148566 T>C,G), RS1000051694 (1:33234981 A>C), RS1000067945 (1:33287141 A>C), RS1000068851 (1:33280536 C>T), RS1000082373 (1:33162597 C>G,T), RS1000109418 (1:33272033 C>G,T), RS1000114862 (1:33162839 G>A), RS1000143709 (1:33147927 A>G), RS1000152233 (1:33195227 A>G), RS1000157417 (1:33186994 G>A), RS1000173646 (1:33231137 G>A,C), RS1000177490 (1:33295571 A>G), RS1000182130 (1:33195589 C>A), RS1000190113 (1:33286928 G>A), RS1000197274 (1:33151423 A>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST006810_10 | Self-reported risk-taking behaviour | 4.000000e-09 |
| GCST008794_40 | Urinary albumin-to-creatinine ratio | 4.000000e-08 |
| GCST90002381_571 | Eosinophil count | 6.000000e-14 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0008579 | risk-taking behaviour |
| EFO:0007778 | urinary albumin to creatinine ratio |
| EFO:0004842 | eosinophil count |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
38 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects cotreatment, decreases expression, affects expression, increases methylation | 7 |
| Benzo(a)pyrene | decreases methylation, decreases expression | 5 |
| sodium arsenite | decreases expression, increases abundance, increases expression | 4 |
| Cyclosporine | decreases expression | 2 |
| Aflatoxin B1 | decreases expression | 2 |
| aristolochic acid I | decreases expression | 1 |
| FR900359 | affects phosphorylation | 1 |
| bisphenol A | increases expression | 1 |
| butyraldehyde | decreases expression | 1 |
| coumarin | increases phosphorylation | 1 |
| S-(1,2-dichlorovinyl)cysteine | decreases expression, affects response to substance, increases expression, affects cotreatment | 1 |
| beta-methylcholine | affects expression | 1 |
| monomethylarsonous acid | decreases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| ICG 001 | increases expression | 1 |
| abrine | decreases expression | 1 |
| ON 01910 | increases expression | 1 |
| dorsomorphin | decreases expression, affects cotreatment | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Temozolomide | increases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Arsenic | increases abundance, increases expression | 1 |
| Azathioprine | decreases expression | 1 |
| Cadmium | decreases expression, increases abundance | 1 |
| Caffeine | affects phosphorylation | 1 |
| Calcitriol | decreases expression | 1 |
| Hydrogen Peroxide | affects expression | 1 |
| Lipopolysaccharides | decreases expression, affects response to substance, increases expression, affects cotreatment | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Quercetin | decreases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_XW37 | HEK293 eGFP-ZNF362 | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.